Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
73 /100
HIGH RISK
Score updated Aug 28, 2026

RCEL — AVITA Medical, Inc. Dilution Risk Tracker

Track RCEL dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track RCEL — Get alerts when the score changes →

As of August 28, 2026, AVITA Medical, Inc. (RCEL) has a DilutionWatch DilutionScore of 73/100, rated HIGH dilution risk. AVITA Medical, Inc. has a market capitalization of $133.26M, 30.93M shares outstanding, 80 institutional holders tracked. Stored dilution-related fields include shelf registration capacity of $200.00M.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
92
💰 Cash Runway
95
📊 Float Risk
10
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

⛈️
Warning
High probability of dilution event
model est. 44%
💰 Capital Raise model 75%
• Critical: only 2.7 months cash remaining
• Active shelf registration ($200M, 150% of market cap)
🔄 Reverse Split model est. 15%
• Only 3 months cash — financial pressure
📉 Score Deterioration model 10%
• Score in HIGH risk zone (73/100)
🔔 Track RCEL — Get forecast alerts →

Market Data

Market Cap$133.26M
Shares Outstanding30.93M
Float30.42M
Cash$11.13M
Debt$46.66M
Short InterestN/A

Institutional Holdings

80 institutional holders · 89.18M shares
#1 ORBIMED ADVISORS LLC 82.01M shares
#2 VANGUARD CAPITAL MANAGEMENT LLC 2.67M shares
#3 BlackRock, Inc. 1.13M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest2.61M
Days to Cover11.1
% of Float8.6%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2025-12-31
EFFECT EFFECT 2026-04-09
S-3 SHELF 2026-03-31
4 INSIDER TRANSACTION 2026-03-11
3 FORM3 2026-03-06
Full SEC filing analysis available with free account

Recent News

No recent news

Factual RCEL Dilution Snapshot

AVITA Medical, Inc. (RCEL) has a DilutionScore of 73/100, rated High dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track RCEL Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking RCEL — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for RCEL
RCEL FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.